Immutep (NASDAQ:IMMP) Stock Price Crosses Above 50 Day Moving Average of $2.35

Immutep Limited (NASDAQ:IMMPGet Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.35 and traded as high as $2.47. Immutep shares last traded at $2.33, with a volume of 112,564 shares.

Immutep Stock Performance

The business’s fifty day moving average price is $2.35 and its two-hundred day moving average price is $2.15. The company has a quick ratio of 13.81, a current ratio of 17.24 and a debt-to-equity ratio of 0.01.

Institutional Trading of Immutep

A number of large investors have recently made changes to their positions in the business. Virtu Financial LLC bought a new stake in shares of Immutep in the 4th quarter worth about $29,000. GTS Securities LLC bought a new position in Immutep during the 4th quarter valued at about $59,000. Meridian Wealth Management LLC grew its holdings in Immutep by 3.6% during the 4th quarter. Meridian Wealth Management LLC now owns 322,450 shares of the biotechnology company’s stock valued at $774,000 after purchasing an additional 11,250 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Immutep by 27.8% during the 4th quarter. BNP Paribas Financial Markets now owns 30,600 shares of the biotechnology company’s stock valued at $73,000 after purchasing an additional 6,665 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Immutep by 15.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 81,928 shares of the biotechnology company’s stock valued at $138,000 after purchasing an additional 10,813 shares during the last quarter. 2.32% of the stock is currently owned by institutional investors.

Immutep Company Profile

(Get Free Report)

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.

Read More

Receive News & Ratings for Immutep Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immutep and related companies with MarketBeat.com's FREE daily email newsletter.